Stay updated on OPTIMISE Clinical Trial: Secukinumab in Psoriasis
Sign up to get notified when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.

Latest updates to the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page
- CheckyesterdayChange DetectedA new revision label v3.5.5 was added to the page's revision history, and the previous label v3.5.4 was removed. This indicates the page content has been updated to a newer version.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a minor update to the page’s revision history. The change does not modify content or user-facing features.SummaryDifference0.0%

- Check29 days agoChange DetectedUpdated the study location entry to Malmö, Sweden, SE-205 02. The previous listing Malmo, Sweden, SE-205 02 was replaced to reflect the correct spelling.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, indicating a refreshed version of the content with minor edits to the study record.SummaryDifference0.0%

- Check51 days agoChange DetectedRevisions were updated to replace v3.5.0 with v3.5.2.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision 3.5.0 was added to the revision history, and Revision 3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to OPTIMISE Clinical Trial: Secukinumab in Psoriasis
Enter your email address, and we'll notify you when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.